Guizhou Bailing Group Pharmaceutical Co Ltd
Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines … Read more
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.090x
Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a cash flow conversion efficiency ratio of 0.090x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.76 Million) by net assets (CN¥3.28 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guizhou Bailing Group Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
InMode Ltd
NASDAQ:INMD
|
0.033x |
|
TRTPF
PINK:TRTPF
|
N/A |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
0.017x |
|
Wuxi Huadong Heavy Machinery Co Ltd
SHE:002685
|
0.044x |
|
TVS Holdings Limited
NSE:TVSHLTD
|
-0.376x |
|
Arctech Solar Holding Co Ltd
SHG:688408
|
0.068x |
|
PTT OIL+RET.BUS.-FOR-BA10
F:7F8
|
N/A |
|
Jiangsu Yahong Meditech Co. Ltd.
SHG:688176
|
-0.062x |
Annual Cash Flow Conversion Efficiency for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.20 Billion | CN¥9.02 Million | 0.003x | -92.09% |
| 2023-12-31 | CN¥3.53 Billion | CN¥125.77 Million | 0.036x | -71.62% |
| 2022-12-31 | CN¥4.00 Billion | CN¥502.15 Million | 0.126x | +53.13% |
| 2021-12-31 | CN¥3.96 Billion | CN¥324.92 Million | 0.082x | +38.77% |
| 2020-12-31 | CN¥3.92 Billion | CN¥231.78 Million | 0.059x | -47.68% |
| 2019-12-31 | CN¥4.14 Billion | CN¥467.41 Million | 0.113x | +381.70% |
| 2018-12-31 | CN¥3.92 Billion | CN¥-157.45 Million | -0.040x | -274.11% |
| 2017-12-31 | CN¥3.47 Billion | CN¥79.88 Million | 0.023x | -84.86% |
| 2016-12-31 | CN¥3.07 Billion | CN¥466.62 Million | 0.152x | -1.24% |
| 2015-12-31 | CN¥2.68 Billion | CN¥413.23 Million | 0.154x | -8.57% |
| 2014-12-31 | CN¥2.35 Billion | CN¥395.83 Million | 0.169x | +153.01% |
| 2013-12-31 | CN¥2.13 Billion | CN¥141.76 Million | 0.067x | +597.39% |
| 2012-12-31 | CN¥2.04 Billion | CN¥19.52 Million | 0.010x | -90.82% |
| 2011-12-31 | CN¥1.94 Billion | CN¥201.90 Million | 0.104x | +142.93% |
| 2010-12-31 | CN¥1.85 Billion | CN¥-447.68 Million | -0.242x | -172.42% |
| 2009-12-31 | CN¥374.42 Million | CN¥125.31 Million | 0.335x | +317.54% |
| 2008-12-31 | CN¥262.75 Million | CN¥-40.42 Million | -0.154x | +64.59% |
| 2007-12-31 | CN¥182.68 Million | CN¥-79.37 Million | -0.434x | -- |